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Purpose: FLASH radiotherapy (FLASH-RT) is a novel irradiation modality with ultra-high dose
rates (>40 Gy/s) that have shown tremendous promise for its ability to enhance normal tissue sparing
while maintaining comparable tumor cell eradication toconventional radiotherapy (CONV-RT). Due
to its extremely high dose rates, clinical translation of FLASH-RT is hampered by risky delivery and
current limitations in dosimetric devices, which cannot accurately measure, in real time, dose at dee-
per tissue. This work aims to investigate ionizing radiation acoustic imaging (iRAI) as a promising
image-guidance modality for real-time deep tissue dose measurements during FLASH-RT. The
underlying hypothesis is that iRAI can enable mapping of dose deposition with respect to surround-
ing tissue with a single linear accelerator (linac) pulse precision in real time. In this work, the rela-
tionship between iRAI signal response and deposited dose was investigated as well as the feasibility
of using a proof-of-concept dual-modality imaging system of ultrasound and iRAI for treatment
beam co-localization with respect to underlying anatomy.
Methods: Two experimental setups were used to study the feasibility of iRAI for FLASH-RT using
6 MeV electrons from a modified Varian Clinac. First, experiments were conducted using a single
element focused transducer to take a series of point measurements in a gelatin phantom, which was
compared with independent dose measurements using GAFchromic film. Secondly, an ultrasound
and iRAI dual-modality imaging system utilizing a phased array transducer was used to take coregis-
tered two-dimensional (2D) iRAI signal amplitude images as well as ultrasound B-mode images, to
map the dose deposition with respect to surrounding anatomy in an ex vivo rabbit liver model with a
single linac pulse precision.
Results: Using a single element transducer, iRAI measurements showed a highly linear relationship
between the iRAI signal amplitude and the linac dose per pulse (r2 = 0.9998) with a repeatability
precision of 1% and a dose resolution error <2.5% in a homogenous phantom when compared to
GAFchromic film dose measurements. These phantom results were used to develop a calibration
curve between the iRAI signal response and the delivered dose per pulse. Subsequently, a normalized
depth dose curve was generated that agreed with film measurements with an RMSE of 0.0243, using
correction factors to account for deviations in measurement conditions with respect to calibration.
Experiments on the ex-vivo rabbit liver model demonstrated that a 2D iRAI image could be generated
successfully from a single linac pulse, which was fused with the B-mode ultrasound image to provide
information about the beam position with respect to surrounding anatomy in real time.
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Conclusion: This work demonstrates the potential of using iRAI for real-time deep tissue dosimetry
in FLASH-RT. Our results show that iRAI signals are linear with dose and can accurately map the
delivered radiation dose with respect to soft tissue anatomy. With its ability to measure dose for indi-
vidual linac pulses at any location within surrounding soft tissue while identifying where that dose is
being delivered anatomically in real time, iRAI can be an indispensable tool to enable safe and effi-
cient clinical translation of FLASH-RT. © 2020 American Association of Physicists in Medicine
[https://doi.org/10.1002/mp.14358]
Key words: FLASH radiotherapy, In vivo dosimetry, medical imaging, radiation acoustics,
ultrasound
1. INTRODUCTION
A major goal of radiotherapy (RT) is to improve cancer eradi-
cation while minimizing complications to surrounding nor-
mal tissues. In a conventional radiotherapy (CONV-RT)
setting, image-guidance techniques and virtual simulations
during treatment planning are typically used to ensure that
the planned irradiation beam delivered from a linear accelera-
tor (linac) conforms to the targeted cancer area while mini-
mizing dose exposure to surrounding normal tissues.
However, several studies have highlighted discrepancies
between planned and delivered radiation treatments and their
impact on tumor eradication and surrounding normal tissue
injury.1 Unfortunately, these differences are exacerbated due
to accumulative setup errors and organ motions over the
course of fractionated radiotherapy treatment. This is particu-
larly true for a novel irradiation modality, known as FLASH
radiotherapy (FLASH-RT), where an ultra-high dose rate
(>40 Gy/s) is being delivered almost instantaneously, which
is orders of magnitude higher than conventional dose rates
(~0.1 Gy/s).2–5
Interest in FLASH-RT has surged recently because of its
unique ability to increase the differential effect between nor-
mal tissue and tumors, hence, improving the therapeutic ratio
by at least 20%–30% in preclinical studies. These encourag-
ing results have been demonstrated in many in vivo systems.
For example, it has been demonstrated in mice that irradiation
under FLASH-RT conditions had reduced deleterious neu-
rocognitive effects (deficits in learning and memory) com-
pared with mice treated with conventional RT.2–5
Additionally, studies with mice have also shown a significant
reduction in lung fibrosis.6,7 Furthermore, the benefits of
FLASH have been seen in higher mammals. Previous work
with FLASH dose rates has shown that skin toxicities were
reduced (no severe late skin fibronecrosis observed using
FLASH, for example) in mini-pigs and toxicities (mucositis
and depilation) were reduced in cats being treated for squa-
mous cell carcinoma of the nasal planum 8. Most recently, a
clinical study was performed on a 75-yr-old patient who pre-
sented with cutaneous lymphoma.9 The patient was treated
successfully with a single 15 Gy FLASH-RT fraction in
90 ms with minimal side effects, demonstrating the potential
of FLASH-RT but also revealing its current clinical limitation
as a surface-based RT only modality where safe irradiation
with common techniques using established dosimetry is
permissible. Applying the promise of FLASH-RT beyond
surface irradiation, however, is hampered by the lack of
proper dosimetric methods, which are able to accurately mea-
sure, in real time, irradiation dose in deeper tissues to ensure
safe delivery. Hence, there is a need to investigate new
FLASH imaging technologies to address this challenge as
presented in this work.
Typically, a clinical linac delivers radiation dose in a series
of pulses. In CONV-RT, the dose per pulse is small
(~0.05 cGy) with respect to the total dose typically used in
treatment, allowing the mean dose rate to be measured by
averaging dose over seconds or minutes. Due to the high dose
per pulse used during FLASH-RT (~ 20 cGy), only a handful
of pulses would be used in each treatment, thus dose mea-
surements on a pulse-to-pulse basis become essential, if not
mandatory.10 The gold standard for radiation beam characteri-
zation is ionization chambers (IC). Using ICs at the ultra-high
FLASH dose rates can become problematic due to the
reported decrease of ion collection efficiency with increased
dose per pulse, requiring the use of an empirical model for
additional correction factors.11 For high dose rate dosimetry,
film can be appropriate as it has been found to be dose rate
independent12 and can be placed directly on the surface of
the patient. However, film is not a real-time measurement nor
it can be used in vivo, thus it is better suited for quality assur-
ance of the treatment plan rather than in vivo dosimetric mea-
surement as would be needed for safe FLASH-RT delivery. It
is important to point out that even though some current
dosimetry methods can be used for FLASH-RT, they are lim-
ited to surface measurements and do not allow for any real-
time feedback, dose measurement in deeper tissue, or map-
ping the irradiated treatment volume for each linac pulse. For
clinical translation of FLASH-RT, it will be highly valuable
to quantify the deposited dose for individual linac pulses at
the treatment volume at depth (as opposed to surface mea-
surements only) as well to register this dose with the patient’s
anatomy irradiated to ensure that the dose is deposited accu-
rately and safely at the intended target in real time.
Ionizing radiation acoustic imaging (iRAI) is an emerging
medical imaging and real-time dosimetry modality that
allows for such online in vivo deep tissue dosimetry.13,14 As
ionizing radiation from the linac goes through tissue, it is
attenuated, depositing energy. This absorbed energy, which is
quantified as dose, in the targeted tissue will cause local, tran-
sient temperature rise in the irradiated volume. The heating
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causes a transient thermal expansion, which generates an ini-
tial pressure which propagates as acoustical waves, in what is
known as the thermoacoustic effect.15,16 This elastic wave,
containing information about the targeted tissue and radiation
absorption, can be collected by ultrasound transducers
located on the surface of the body around a region of interest.
Since for a given tissue structure and beam geometry, the ini-
tial pressure is linearly proportional to the energy deposited
(radiation dose), both the beam location and the dose deposi-
tion information can be extracted from the detected pressure
wave. Therefore, we hypothesize here that, when iRAI is
combined with ultrasound imaging (US), this dual-modality
imaging will provide an effective way to guide FLASH-RT
delivery safely, in vivo, in real time. Specifically, iRAI would
allow for real-time imaging of dose deposition that can be
inherently registered with the exposed tissue anatomy image
from US.17,18 Several previous studies have demonstrated the
feasibility of iRAI in providing clinically acceptable dosime-
try from photons and electrons using either nontomographic
or tomographic (XACT) methods during external beam radia-
tion therapy,15,16,19,20 as well as some early work on using the
radiation acoustics generated from a pulsed proton beam to
study the feasibility for noninvasive dose monitoring of a
patient’s liver.21 However, the linearity of iRAI as a dosimetry
tool under extremely high dose rates and the potential appli-
cation of iRAI to guide FLASH-RT still have not been
explored.
In this work, and for the first time to the best of our knowl-
edge, this novel dosimetry method, iRAI, is proposed for
FLASH-RT allowing for deep tissue real-time dosimetry,
which would constitute a major breakthrough towards safe
clinical implementation of FLASH-RT. The feasibility of
using iRAI for dosimetric measurements by investigating the
relationship between the generated iRAI signal during deliv-
ery and the absorbed deposited dose, as well as real-time dose
mapping tool using a proof-of-concept US and iRAI dual-
modality imaging system, are evaluated via experiments in
both phantoms and soft tissue samples during FLASH-RT.
2. MATERIALS AND METHODS
2.A. Theory
In the processing of electron beam radiation therapy, the
Linac-generated high energy electron beam impinged on the
targeted tissue medium causing Coulomb interactions
between the incident electrons and orbital electrons of the
medium, resulting in ionizations of the medium atoms, or
interaction with the nuclei of the medium atoms, resulting in
electron scattering and energy loss of the electron through
production of x-ray photons (bremsstrahlung). These energy
losses are characterized by mass–energy stopping power (S/
ρ), where S is the loss of the kinetic energy of the electron
per unit length and ρ is the density of the medium. These
losses determine the electrons’ travel range. The ionization
interactions contribute to the deposited dose rate during this
pulse:




where ; is fluence rate, i.e., the number of electrons per unit
area (electron fluence) per unit time produced during a pulse.
The “col” subscript refers to the collisional (ionization) part
of the mass–energy stopping power. The local heat produced
can then be given by:
H r, tð Þ¼ ηthρDr r, tð Þ (2)
where H r, tð Þ is the heat absorption rate at location r∈R3 and
time t, and ηth is the thermal efficiency. The temperature rise
distribution T(r, t) due to H r, tð Þ follows the heat transfer
equation:
ρCv
∂T r, tð Þ
∂t
¼ λr2T r, tð ÞþH r, tð Þ (3)
where Cv is specific heat capacity, and λ is the thermal con-
ductivity. Following our previous approach,13 this can be
rewritten as:
∂T r, tð Þ
∂t
¼ ηthDr r, tð Þ
Cv
(4)
Hence, the wave equation governing the generation and







p r, tð Þ¼βKTηth
v2sCv







is the speed of sound, β is the volumetric
thermal expansion coefficient, and KT is the isothermal bulk
modulus. To match the frequency bandwidth of the radiation-
induced acoustic signal, low frequency transducer probes
were employed in this study. The temporal profile of each
electron beam pulse can be represented as a Dirac delta func-
tion.13 Hence, the iRAI pressure detected at the transducer
position r and time t can be expressed by:





r r0j jΓηthρDp r





where Dp r0ð Þ ¼Dr r, tð Þ  τp is the deposited dose due to a
signal electron beam pulse, τp is the pulse duration of elec-





This is a tissue specific parameter. It is noticed from Eq.
(6) that the pressure wave is directly proportional to the
Grüneisen parameter and the rate of change in the deposited
dose. In the case of CONV-RT, this would be on the order of
0.05 cGy per pulse, which corresponds to an acoustic pres-
sure on the order of 10 mPa. Measuring of such a small pres-
sure would require a high gain signal amplification and
substantial signal averaging to enhance the signal-to-noise
ratio (SNR), as described in our previous work.13 In the case
of FLASH-RT, the dose per pulse is on the order of 20 cGy,
leading to an acoustic pressure on the order of 4 Pa. This
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pressure level is well above the detectable pressure by current
commercially available transducers, and hence eliminates the
need for high gain signal amplification and extensive signal
averaging as in CONV-RT applications. Depending on the
level of the iRAI signals generated, the dynamic range of the
acquisition system can be adjusted to utilize the full range
while preventing signal saturation. This unique capability for
single-pulse dosimetry with iRAI constitutes much of the
motivation for this work.
2.B. Dosimetry nomenclature
Typically, in CONV-RT, the dose rate that is reported is
the average dose rate, Dr, which is the dose deposited over a
specified time frame (i.e., Gy/min or Gy/s). Additionally,
dose rate can be defined as the rate at which the dose is
deposited over a single linac pulse, this is known as the in-
stantaneous dose rate, _Dr (Gy/s). With FLASH-RT using a
pulsed delivery system, such as a linac, it is useful to consider
the amount of dose that is deposited from a single pulse, Dp,
(Gy/pulse) since the full prescribed dose can be delivered
over a handful of pulses. In this work, iRAI signal amplitudes
are compared to Dp, the delivered dose per pulse.
2.C. FLASH electron source
A Varian Clinac 2100EX (Varian Medical Systems, Palo
Alto, Ca) linear accelerator (linac) was used to assess iRAI
for real-time dosimetric imaging with electron beams at
FLASH-RT level dose rates. All modifications were done
during the decommissioning of this linac machine. In order
to achieve FLASH dose rates (>40 Gy/s), the linac was oper-
ated in 6 MV photon mode (which, typically, has the highest
electron current compared with other modes) with the target
and the flattening filter removed. The target is made to retract
in 6 MV mode by reversing the wiring to the gantry air mani-
fold, which activates the solenoids for positioning the target
for low energy x-ray mode vs electron mode. Prior to the tar-
get removal, the electron current at the target was measured
through the “Target” BNC connector on the control panel to
be 100 mA. The monitor chamber functioned as a scattering
foil, spreading out the electron beam.
The objective of this configuration was to achieve flash
dose rates at the nominal linac gantry isocenter, for this linac
at 100 cm source-axis distance (SAD). This configuration
was different from previous work in the literature, which
focused on reversible linac modifications where the linac was
running in electron mode (smaller electron current) and mea-
surements took place within the linac head.22,23 The method
chosen for this study removed the previous constraint of lim-
ited space within the linac head, allowing for flexibility in
experimental designs for iRAI in this proof-of-concept study.
However, the major downside of this modification is that it is
currently irreversible. Therefore, the FLASH modifications
were only made after the linac was no longer needed for clini-
cal care.
The beam was controlled using an Arduino Uno micro-
controller that was connected to the beam hold card. This
allowed control of the time that the beam was turned on to be
as low as 1 ms. The desired beam run time was entered using
a keypad (as shown schematically in Fig. 1) that was pro-
grammed into the Arduino. During beam delivery with ser-
vice mode, the beam would be turned on and the Arduino
would maintain this beam hold until the trigger, releasing the
beam for the desired time.
2.D. Film dosimetry
Dose was measured using GAFChromic EBT-XD dosime-
try film (Ashland Advanced Materials), which was scanned
using an Expression 10000XL (Epson) flatbed scanner at a
resolution of 72 dpi. All films were analyzed using the
FilmQA Pro 2016 software (Ashland Advanced Materials)
with the dose map being generated using the built-in triple
channel uniformity optimization algorithm. Dose was deter-
mined from an average of a 0.2 cm × 0.2 cm region of inter-
est at the central axis of the beam. Calibration was done
using a 10 cm × 10 cm field of 6 MV photons at reference
conditions, where the film was placed at 100 cm source-to-
axis distance (SAD) with 10 cm of Solid Water (Sun Nuclear
FIG. 1. A schematic and a photo of the Arduino-based control system which is connected to the Linac beam hold card to control the time the beam is turned ON.
[Color figure can be viewed at wileyonlinelibrary.com]
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Corporation) placed on top with a calibration range of 0 to
50 Gy. The dose per pulse was determined by dividing the
measured dose from film during a specified timeframe by the
known number of pulses acquired during the same period.
2.E. Linac pulse monitoring
For this study, individual linac pulses were used as acqui-
sition trigger signals for iRAI. This was accomplished by
measuring the Cerenkov Emission (CE) generated in a water/
glycerin solution using a silicon avalanche photodiode (Thor-
labs APD101A) during each single pulse.24 The container
holding the solution was wrapped in light-blocking masking
tape (Thorlabs, T743) to prevent photodetector saturation due
to ambient lights. This device was placed before the electron
beam was collimated and was out of the central axis of the
beam, relying off scattered electrons to generate the CE dur-
ing the time period when the beam was ON. The signal from
the avalanche diode was carried over a 15m BNC cable
(50 Ω) from the treatment room to the linac control room and
was amplified (Olympus, 5072PR) and sent to a delay gener-
ator (Stanford Research Systems, DG535) to generate a per-
fect square pulse, which then went through a splitter, one
signal to an analogue pulse counter (Tennelec, TC 532) and
the other to the trigger input of the iRAI acquisition systems,
as shown in the schematic in Fig. 2.
2.F. iRAI dose measurements
To investigate the linearity of the iRAI signal amplitude
with the dose delivered in each linac pulse, the dose per pulse
was varied and compared with the resultant iRAI signal
amplitude. Since the electron beam was diverging, the dose
per pulse was changed by varying the distance between the
beam source (defined where the linac bremsstrahlung target
would have been if it were in place) and the transducer scan-
ning plane, which was referred to as the source-axis distance
(SAD), as shown in Fig. 2. The SAD range was 100–210 cm
with a step size of 10 cm. The dose sensitivity and accuracy
were further evaluated by adjusting the SAD from 102 to
104 cm with a finer increment size of 0.5 cm. At each SAD
position, the iRAI acoustic signal was measured and was
repeated 30 times for further statistical analysis.
A custom-built collimator made from water equivalent
plastic (Solid Water, Gammex) was placed in front of the
phantom to shape the incident electron beam down to a
1 × 1 cm2 field. A cylindrical phantom (diameter of
100 mm) made of porcine gelatin (10 g/100 ml, G2500,
Sigma-Aldrich) was used to generate the iRAI signals. The
ultrasound transducer was a cylindrically focused immersion
transducer (12550 1001, Imasonic) with a central frequency
of 0.5 MHz and a 6 dB bandwidth of 60%. The transducer
was placed on the cylindrical surface of the phantom and
coupled with ultrasound gel. This selection was based on pre-
vious experimental work.14
The iRAI acoustic wave generated from the irradiated area
within the phantom propagated through the phantom and was
detected by the ultrasound transducer. The detected iRAI sig-
nal was amplified by a preamplifier (5660B, Olympus-NDT)
with a 40 dB gain before going to the data acquisition (DAQ)
system, which is placed outside of the treatment room. The
DAQ system included a 14-bit digitizer card (Razor 14,
GaGe) with a sampling rate of 10 MHz. Data acquisition was
triggered using the Linac Pulse Monitoring system described
above (Fig. 2).
Film was used as a standard dosimetric device to correlate
iRAI signal amplitudes with the generated dose per pulse,
Dp. At the same SAD positions as the iRAI measurements,
film measurements were performed with 150 ms of electron
beam illumination (controlled using the Arduino card) with
the number of linac pulses counted using an analogue pulse
counter. The film was placed in between two pieces of solid
water. The side facing the collimator was 1 cm thick (for dose
buildup) and the other piece of solid water on the film side
facing away from the collimator was 2 cm thick (for
backscatter and mechanical support).
FIG. 2. Schematic of the system setup for ionizing radiation acoustic imaging (IRAI) dosimetric measurement including the linac, the trigger system (Avalanche
Photodiode, Pulse/Receiver, and Delay Generator), and the iRAI system (Transducer, Pre-Amp, and DAQ system). [Color figure can be viewed at wileyonlinelib
rary.com]
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2.G. Depth-dependent dose measurements
To measure how the deposited dose changes with tissue
depth (defined as a percentage depth dose [PDD] curve) dur-
ing FLASH-RT, a special phantom consisting of porcine
gelatin and water fixed in a water tank was used. As shown in
Fig. 3, the transducer was immersed in water on one side of
the tank for acoustic coupling during the scanning process.
The other side of the tank was made of porcine gelatin with
10 cm removed from the front to get a sharp front edge while
also allowing the center of the transducer to be aligned with
this front edge of the gelatin. To minimize any additional
scattering of the electron beam, the wall of the water tank
along the beam path was removed. The solid water collimator
(1 cm × 1 cm) was placed at the surface of the water tank
and the collimated electron beam travelled through 10 cm of
air before hitting the front edge of the gelatin phantom. The
initial position of the transducer was where the center of the
transducer focal plane aligned with the front edge of the
phantom. The distance between the center of the electron
beam and the detection surface of the transducer was 11.2 cm
(the focal length of the focused transducer). The transducer
was fixed to a motorized translation stage using optical rods
(Low-Profile Motorized Translation Stage, MTS50-Z8, Thor-
labs) to allow the focus of the transducer to be scanned along
the electron beam path through the phantom (as denoted by
the blue arrow in Fig. 3) for a distance of 30 mm with a step
size of 2 mm. The iRAI acoustic signal was measured 30
times at each position for statistical evaluation. Film measure-
ments were setup using a custom 3D printed Gafchromic film
holder with the distance of 2 mm between each piece of film.
The first position of the film (on the surface of the custom
holder) was the same as the front edge of the gelatin phan-
tom. The gaps between each adjacent films were filled with
water to achieve similar radiation attenuation as porcine gel.
To accumulate a sufficient dose for film analysis, 500 ms
(150 pulses) of irradiation time was used.
In the previous section, we outlined how the relationship
between the deposited dose and iRAI amplitude was measured
in a gelatin phantom using film dosimetry. This relationship
can be used as part of the calibration process between the mea-
sured iRAI amplitude and the deposited dose (in gelatin). Dur-
ing those measurements, the depth at which the transducer
was sampling the iRAI amplitude within the gelatin phantom
was held constant as the dose rate was varied. During the
depth-dependent dose measurements, however, the transducer
was repositioned to sample various depths within the gelatin
phantom. Therefore, a correction factor is needed to take into
account the relative electron energy and fluence changes with
respect to the calibration conditions (i.e., to recover what the
measurement would have been at the conditions where the
relationship between the iRAI amplitude and dose was mea-
sured). Consider the following relationship:
DiRAI að Þ≡f að Þ (8)
where the iRAI dose, DiRAI að Þ, is related to the fitted function
used for calibration, f að Þ, where “a” is the iRAI signal ampli-
tude. This relationship only holds true if the phantom mate-
rial is constant (in this case gelatin) and the measurement
location within the phantom is the same as what was used for
the iRAI dose measurements previously described. Thus, a
depth-dependent correction factor, γ zð Þ, is used to take into
account measurement parameter changes as follows:
DiRAI a,zð Þ¼ f að Þ  γ zð Þ (9)
Dose is a function of two parameters for electrons: the
stopping power, Sρ
 
, and the fluence, ϕ, as shown in Eq. (1).
Hence, the correction factor itself consists of two compo-
nents, one taking into account the relative electron stopping
power with depth z, C S
ρð Þ zð Þ, and the other taking into account
the relative fluence changes, Cϕ zð Þ, which are derived in the
following:
γ zð Þ¼C S
ρð Þ zð Þ Cϕ zð Þ (10)
Stopping power is electron energy dependent, as electrons
transverse the phantom their energies change as a function of
depth. Here, we estimate the energy change using the follow-
ing equation,25 where the practical length, Rp, is estimated to
be 3 cm for an electron beam with a nominal energy, E0, of
6 MeV.
E zð Þ¼E0 1 zRp
 
(11)
The stopping powers at each depth measurement point are
determined using the energies provided from the expression
FIG. 3. The system setup for depth-dependent dose measurement. (a) Schematic of the system setup; (b) Photograph of the system setup. [Color figure can be
viewed at wileyonlinelibrary.com]
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above and looked up using NIST tables (using the values for
water). The correction factor,C s
ρð Þ zð Þ, is a ratio of the stop-
ping power at each measurement point and the stopping
power at the measurement point used in the calibration:
C S




In order to take into account the change in fluence with
respect to the calibration condition, a Monte Carlo simulation
(EGSnrc) is used to determine fluence values as a function of
depth for a respective material, which in this case is gelatin.
The correction factor for relative fluence changes, Cϕ zð Þ, is
the ratio between the fluence at each depth ϕ Zð Þ, and the flu-
ence at the calibration measurement point, ϕ0:
Cϕ zð Þ¼ϕ zð Þ
ϕ0
(13)
2.H. Real-time dual-modality imaging for dose
mapping
A cylindrical porcine gelatin phantom (diameter =
100 mm) with a whole rabbit liver embedded was used to
evaluate the feasibility of real-time single-pulse dose map-
ping with respect to soft tissue anatomy. This was achieved
using a clinically ready integrated dual-modality imaging sys-
tem that was adapted from a commercially available research
ultrasound (US) platform (Verasonics, Vantage 256). This
system was used in this study for both iRAI and B-mode US
imaging. With 256 parallel channels, two phased array probes
(Philips P4-1, 1–4 MHz, 96 elements) were driven by this
system simultaneously. The two probes were oriented orthog-
onally (90° angle) with both probes facing the center of the
sample (as shown on the right in Fig. 4). The sample which
was subsequently irradiated with electrons from the top with
a solid water collimator above the sample to shape the beam
to a 1 cm × 1 cm square (as shown in Fig. 4). The trans-
ducer scan plane was 100 cm SAD where a dose rate of
25 cGy per pulse was achieved.
The triggers from the delay generator of the linac pulse
monitoring system were sent to the dual-modality imaging
system for synchronization. The iRAI signals from each linac
pulse were acquired by the imaging system with IRAI images
reconstructed and displayed in real time. For US B-mode, the
probes were driven by the Verasonics system which displayed
the B-mode images every six trigger events (linac pulses) for
tracking continuous tissue motion. The current dual imaging
system can operate in the iRAI mode and the US mode alter-
natively, as described in previous work.18 Briefly, during the
“beam ON” portion of the irradiation duty cycle, the trans-
ducers measured the iRAI signals in a receive-only mode;
while during the “beam OFF” portion, the same transducers
were used to generate a B-mode US image. The two iRAI
images acquired by the two probes were compounded. The
same step was performed for the two US images. Then, regis-
tration was accomplished by overlaying the resultant iRAI
image on the US B-mode image. Both the probes and phan-
tom were immersed in water for ultrasound coupling. To
mimic the organ motion, the phantom was driven by a motor-
ized stage (Low-Profile Motorized Translation Stage,
MTS50-Z8, Thorlabs) moving in the direction along the
green arrow, as shown in Fig. 4, at a velocity of 3 mm/s. Over
a time period of 16.7 s, the sample moved a total distance of
50 mm.
3. RESULTS
3.A. Linearity of iRAI dosimetric measurement
Figure 5(a) presents the detected iRAI signal amplitude as
a function of SAD compared with film dosimetry. The box-
plot consists of 30 measurements at each SAD, demonstrat-
ing the high stability of iRAI for dosimetric measurements.
The film measurements show that the dose per pulse
decreases with increasing SAD, ranging from 24.5 cGy/pulse
at 100 cm SAD to 1.4 cGy/pulse at 210 cm SAD. iRAI
amplitude measurements followed the same decreasing trend
with a root mean square error (RSME) of 0.00073. When
FIG. 4. The system setup for real-time dual-modality imaging for dose mapping. (a) Schematic of the system setup. (b) The photograph of the system setup.
[Color figure can be viewed at wileyonlinelibrary.com]
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plotting the iRAI signal amplitude versus the film measured
dose per pulse, Dp, as shown in Fig. 5(b), a linear relation-
ship is found with an r2 value of 0.9998, demonstrating high
linearity for iRAI dosimetric measurements. The fitting line
with proportionality factor of 0.0047 is consistent with the
theory of iRAI dosimetric measurement described in Eq. (6).
3.B. Dose sensitivity of iRAI dosimetric
measurements
For this set of measurements, the SAD step size was
reduced to 0.5 cm to assess the dose sensitivity of iRAI. Fig-
ure 6 compares both the measured iRAI signal amplitude and
the normalized dose per pulse derived from film dosimetry as
a function of SAD. A dose fitting line based on the attenua-
tion equation (inverse square law) of electron beam in air was
extracted with the data of the linearity measurement shown in
Fig. 5(b). Although the slope of the film measurement and
the calculated dose as a function of SAD is the same, the film
measurement shows some offsets in some SADs. With the
iRAI measurements drawn with black error bars, the average
value at each SAD of the iRAI measurements is more consis-
tent with the calculated dose than the film measurement.
Unlike the film measurement at each SAD which reflects the
dose accumulated in 150 ms with 45 pulses, the iRAI mea-
surements at each SAD gives the dose of 30 individual
pulses. The maximum standard deviation of the iRAI based
single-pulse dose measurements over the five SAD positions
is within 1% with an average dose difference between the
SAD steps <2.5%.
3.C. Depth-dependent dose measurements
Figure 7 compares the normalized depth-dependent dose
measurements from iRAI with those from the film dosimetry.
The curve showing the iRAI measured dose. vs. depth (blue
curve) shows similar and expected features as the measure-
ment from the film (black curve), such as a dose buildup
region, a maximum dose point, and a fall off region. The
iRAI voltage vs dose relationship (Fig. 5) was used as a cali-
bration curve for dose measurement. In order to account for
the departure of the calibration conditions in Fig. 5, a correc-
tion factor was introduced that compensated for the electron
beam divergence and its energy changes as a function of
phantom depth using Monte Carlo simulated fluence
changes, as described by Eqs. (8)–(13). The iRAI measure-
ment of the PDD after applying this correction factor, as
shown by the red curve in Fig. 7 improved agreement with
the measurements from the film. Using the film measure-
ments as the gold standard, the RSME of the iRAI measure-
ments was improved from 0.3774 (uncorrected) to 0.0243
(corrected) by applying this correction factor.
FIG. 5. Comparison of ionizing radiation acoustic imaging (IRAI) dose measurement and film measurement. (a) The iRAI dose measurement compared with
film measurement along with different source-axis distance; (b) The linearity of iRAI dosimetric measurement. [Color figure can be viewed at wileyonlinelibra
ry.com]
FIG. 6. The quantified sensitivity and accuracy of ionizing radiation acoustic
imaging dose measurement. [Color figure can be viewed at wileyonlinelibra
ry.com]
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3.D. Real-time dual-modality imaging for dose
mapping
The iRAI and US dual-modality imaging results from the
rabbit liver phantom are shown in Fig. 8. Figure 8(a) shows a
registered and combined iRAI and US image. The iRAI
image and the US image were each acquired by using both of
the two orthogonally oriented probes shown in Fig. 4(b). The
pseudo-color iRAI image shows the boundary of the dose
distribution in red. This illustrates that our transducer’s fre-
quency bandwidth is primarily sensitive to the boundary of
the dose deposition from this large treatment field. The posi-
tion of the delivered high-dose rate electron beam is marked
by the yellow dashed box, which corresponded well with the
iRAI image. During a time period of 16.7 s, the rabbit liver
phantom was translated in one direction (using the motor
drive) during constant irradiation, with both the beam and
transducer positions fixed. With the multi-frame image
shown in Fig. 8(b), the relative dose position in the phantom
as a function of time is mapped successfully. The signal-to-
noise ratio (SNR) of iRAI working with the high dose rates
during FLASH-RT is high enough to allow for imaging with
single linac pulses. Hence, iRAI based imaging of the radia-
tion beam location in the soft tissue samples can work at a
frame rate of 300 Hz (i.e., the linac repetition rate). The video
of this dual-modality imaging result from the ex-vivo rabbit
liver phantom, as shown in Movie S1, has a frame rate of
50 Hz, since the B-mode US images were acquired after
every six linac pulses.
4. DISCUSSION
Compared with CONV-RT, where the prescribed radiation
dose is delivered using hundreds to thousands of linac pulses
over several minutes, FLASH-RT can deliver the same dose
in a fraction of a second using only a handful of high-dose
linac pulses, leading to a transient oxygen depletion effect.
This phenomenon has been demonstrated to be an essential
feature for sparing normal tissue while maintaining the same
efficacy in eradicating tumors, leading to approximately a
20–30% reported reduction in toxicity in preclinical stud-
ies.2–9 However, the translation of FLASH-RT into clinical
practice would require addressing many new implementation
challenges, such as precise pulse-to-pulse dosimetry and pre-
cise beam targeting when delivering such high-dose pulses.
Additionally, knowing what the dose deposition at depth
within tissue and with respect to anatomy would allow for
real-time measurements to identify any regions where the
dose rates may deviate, that is, fall above or below the
FLASH-RT threshold, which can inadvertently lead to severe
normal tissue complications or failed treatment with even
possible death.
The goal of this study is to investigate the feasibility of
iRAI for real-time deep tissue dosimetry with single linac
FIG. 7. Comparison of ionizing radiation acoustic imaging (iRAI) and film
dose measurements as a function of depth. The black curve is the normalized
film measurement, while the blue curve and the red curve are the uncorrected
and the corrected normalized iRAI measurements, respectively. [Color figure
can be viewed at wileyonlinelibrary.com]
FIG. 8. Ionizing radiation acoustic imaging (IRAI) and US dual-modality imaging of a rabbit liver phantom ex vivo. (a) A registered and combined IRAI and US
image. (b) The multi-frame combined images from real-time IRAI and US dual-modality imaging at different time points when the phantom was translated.
[Color figure can be viewed at wileyonlinelibrary.com]
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pulse resolution as well as coregistration of the delivered
dose to exposed soft tissue anatomy during FLASH-RT. For
this proof-of-concept study, a modified clinical linac is used
to deliver 6 MeV electrons at FLASH dose rates at isocenter.
Two measurement setups are used, one based on a single ele-
ment cylindrically focused transducer for point measurements
and the other based on an iRAI and B-mode US dual-modal-
ity system built on a commercial US unit and phase arrays.
Using a single element transducer, the iRAI amplitude is
compared with standard film dosimetry. Intrinsically, the
iRAI signal is the result of a single linac pulse and is thus
proportional to the delivered dose per pulse, Dp. In order to
correlate the iRAI signal with the film result, the Dp is first
derived from the film measurements, which is done by divid-
ing the dose measured by the film by the measured number
of pulses delivered. When compared to the film result, the
iRAI signal amplitude exhibits high linearity (r2 = 0.9998)
with Dp, thus demonstrating the feasibility of iRAI for use as
a dosimeter. Additionally, the experiments conducted for
measuring the accuracy and uncertainty of iRAI measure-
ment shows the average dose difference between each SAD
increment to be about 2.5%. The statistical significance
between the iRAI measurements at different SADs demon-
strates that the dose resolution of this method is smaller than
2.5%. By calculating the standard deviation of the iRAI sig-
nal amplitudes at each SAD, a maximum standard deviation
of 1% is determined which demonstrates the reproducibility
uncertainty of iRAI dosimetric measurement in the homoge-
nous phantom. It is worth noting that in an in vivo system,
this uncertainty is likely to higher, partly due to the differ-
ences in various tissue properties affecting the radiation-in-
duced thermoacoustic effect. However, the use of the dual
iRAI/US imaging system may help mitigate this issue.18
By normalizing the theoretical dose which was fitted using
the linearity measurement and the dose measurement at each
specific position, the correlation between the average values
of the iRAI measurements and the theoretical doses is higher
than the correlation between the film measurements and the
theoretical doses. Since the film measurement is the average
dose integrated over a time period with more than a hundred
single pulses, the variation between the film measurements
and the theoretical doses is within the uncertainty of the iRAI
measurements.
This work also demonstrates the potential of using iRAI for
deep tissue dosimetry. A typical measurement in clinical qual-
ity assurance is the PDD curve where dose is measured as a
function of depth (which is typically done using an ionization
chamber in a water tank). To assess the feasibility of using
iRAI to measure dose at depth, the single element transducer
is used to sample the generated acoustic signal at various
depths. For comparison, dose is also measured with film
placed at various depths in water. Film is chosen over using an
ionization chamber due to recombination saturation during
the ultra-high dose rates of FLASH-RT. As shown in Fig. 5,
the measurement depth for the irradiated beam is kept consis-
tent between the iRAI and the film measurement, including
the 10 cm distance between the collimator and the surface of
the phantom. As electrons travel in the phantom, their spatial
distribution spreads out following a teardrop shape and their
average energy decreases.25 In order to correctly apply the
iRAI voltage vs dose relationship as a function of depth, a cor-
rection factor must be used to compensate the departure from
the fixed measurement condition. This correction factor is
generated using a Monte Carlo simulation (EGSnrc) of elec-
tron transport in medium. It takes into account the relative
energy changing with depth as well as relative fluence changes
(with respect to the calibration conditions) as the beam
spreads out to account for deviations in measurement condi-
tions compared to the calibration conditions at a fixed depth.
When applying the corrections, the iRAI measured dose depth
curve is in closer agreement with the film results. Both the
iRAI and the film show a buildup region, a maximum, and a
fall off region in the depth dose curve. In the buildup region
near the surface, the film measurements had a higher signal.
This is due to how the signal is collected with iRAI. The focal
zone of the transducer is not a point source but a finite volume,
thus is unable to collect the signal from a single plane with an
infinitesimal thickness. When taking measurements at the sur-
face, some of the beam in the focal zone extends out of the
phantom, sacrificing part of the acoustic propagation, thereby
reducing the signal amplitude, which is consistent with the
measurements shown in Fig. 7. The dose depth measurements
using the film and the IRAI show excellent agreement in the
fall off region. When looking at the detection limit of the film
measurement in Fig. 7 at the depth of 26 mm, iRAI can still
detect a relatively strong acoustical signal. Compared with the
film measurement, the standard deviation of the iRAI signals
at each depth are dominated by pulse-to-pulse measurement
fluctuation (which may result from both the stability of data
acquisition system as well as the actual linac pulse-to-pulse
variations), while the film measurement has an average of 150
linac pulses delivered over the irradiation time of 500 millisec-
onds. When considering these uncertainties, the iRAI derived
PDD measurements are consistent with the film measure-
ments. For direct dose measurements on patients, no current
clinical dosimetry method exists for such deep tissue dosime-
try with current methods limited to superficial measurements
as noted earlier. It is worth noting that in future practice, single
element iRAI depth dose measurements will be substituted in
lieu of the use of one-dimensional (1D) or two-dimensional
(2D) phased array transducers to acquire a full 2D/3D images
for accurate spatial dose distribution measurements.
Using the iRAI and US dual-modality system, the ability
to map the deposited dose with respect to tissue anatomy in
real time is demonstrated using an ex-vivo rabbit liver phan-
tom. Figure 8 shows the boundary of the radiation field loca-
tion within the rabbit liver. By taking advantage of the high
SNR from the high dose per pulse in FLASH-RT and the
large number of parallel channels in the research US plat-
form, the dose mapping of the radiation beam and anatomical
information from B-mode ultrasound can be achieved with a
single radiation pulse in real time. Intrinsically, the iRAI and
US images are coregistered since the same probes are used. It
is worth noting here that the dose map generated is based
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upon a relative measurement that demonstrates the ability for
beam colocalization but does not provide an absolute dose
measurement. It is difficult to quantify the exact dose being
deposited since various tissue types are different in an array
of parameters affecting the radiation-induced thermoacoustic
effect. For example, an anatomical feature consisting of
mostly fat with larger Grüneisen parameter would have a lar-
ger iRAI amplitude than surrounding soft tissue being irradi-
ated with the same dose. This means that a simple calibration
using the approximation of a water-based phantom (as used
for the single element transducer studies) may not be appro-
priate. Future work will require iRAI measurements to take
the varying tissue properties, possibly using the dual US
imaging as presented here with further segmentation analysis
of the B-mode image to characterize the different tissue types
in order to provide an accurate absolute dose measurement.
To further advance this technique for clinical translation,
studies on in vivo models as well as more sophisticated iRAI
reconstruction algorithms that take into account tissue inho-
mogeneity for absolute dosimetry are needed. Despite these
limitations, the current results from the two prototype iRAI
systems and the proof-of-concept experiments on the soft tis-
sue phantoms demonstrate the feasibility and accuracy of
iRAI for real-time single radiation pulse deep tissue in vivo
dosimetry during FLASH-RT, as well as real-time mapping
of the dose deposition with respect to surrounding tissue,
which in itself is an important enabling step for the safe clini-
cal translation of FLASH-RT.
5. CONCLUSIONS
This work has demonstrated the potential of using iRAI
for real-time deep tissue dosimetry for FLASH-RT. It is
shown that iRAI signals are linear (r2 = 0.9998) with dose.
In addition, when combined with US imaging, iRAI can map
radiation dose with respect to local soft tissue anatomy. With
its ability to measure dose for individual linac pulses at any
location within soft tissue while knowing where that dose is
being delivered anatomically in real time, iRAI can be a pow-
erful tool to enable safe and successful clinical translation of
FLASH-RT.
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SUPPORTING INFORMATION
Additional supporting information may be found online in
the Supporting Information section at the end of the article.
Video S1. A video of the iRAI and US dual-modality imag-
ing system results from an ex vivo rabbit liver phantom, with
the pseudo-color iRAI image showing the boundary of the
dose distribution in red with a frame rate of 50 Hz.
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